2013
DOI: 10.1182/blood-2013-08-522458
|View full text |Cite
|
Sign up to set email alerts
|

2B or not 2B: when VWF is not a good platelet friend

Abstract: In this issue of Blood, Casari et al demonstrate that mutant platelet survival is shorter and clearance of mutant von Willebrand factor (VWF)-platelet complexes increased in a mouse model of type 2B von Willebrand disease (VWD2B) compared with control mice, providing a comprehensive explanation for thrombocytopenia in VWD2B.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
1
1

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 10 publications
0
1
0
Order By: Relevance
“…18 VWD2B appears to not only be a disorder of a plasma hemostatic protein, but also of platelets, suggesting that, in addition to VWF/factor VIII concentrates, transfusion of normal platelets may be justified in VWD2B patients with bleeding and worsening of their thrombocytopenia due to hemostatic stress situations. 18 Furthermore, recent studies from the same group demonstrated that also platelet dysfunction is present in VWD2B. 19 A dysregulated platelet signaling upon binding to GpIb-α, which severely impairs platelet aggregation, secretion and platelet spreading was in fact demonstrated on the basis of a decreased activation of the platelet fibrinogen integrin receptor αIIbβ3 as a consequence of type 2B VWF binding to GpIb-α.…”
Section: How Type 2b Vwf Influences Plateletsmentioning
confidence: 99%
“…18 VWD2B appears to not only be a disorder of a plasma hemostatic protein, but also of platelets, suggesting that, in addition to VWF/factor VIII concentrates, transfusion of normal platelets may be justified in VWD2B patients with bleeding and worsening of their thrombocytopenia due to hemostatic stress situations. 18 Furthermore, recent studies from the same group demonstrated that also platelet dysfunction is present in VWD2B. 19 A dysregulated platelet signaling upon binding to GpIb-α, which severely impairs platelet aggregation, secretion and platelet spreading was in fact demonstrated on the basis of a decreased activation of the platelet fibrinogen integrin receptor αIIbβ3 as a consequence of type 2B VWF binding to GpIb-α.…”
Section: How Type 2b Vwf Influences Plateletsmentioning
confidence: 99%